Peroxiredoxin isoforms are associated with cardiovascular risk factors in type 2 diabetes mellitus

Peroxiredoxin isoforms are associated with cardiovascular risk factors in type 2 diabetes mellitus

Show other versions (1)

The production of oxygen free radicals in type 2 diabetes mellitus contributes to the development of complications, especially the cardiovascular-related ones. Peroxiredoxins (PRDXs) are antioxidant enzymes that combat oxidative stress. The aim of this study was to investigate the associations betwe...

Full description

Bibliographic Details
Main Authors:	E. El Eter, A.A. Al-Masri
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2015-03-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Peroxiredoxins Type 2 diabetes mellitus Oxidative stress Cardiovascular risk factors
Online Access:	http://www.scielo.br/pdf/bjmbr/v48n5/1414-431X-bjmbr-1414-431X20144142.pdf

Similar Items

Peroxiredoxin isoforms are associated with cardiovascular risk factors in type 2 diabetes mellitus
by: E. El Eter, et al.
Published: (2015-05-01)

The Role of Peroxiredoxins in Cancer Development
by: Pratik Thapa, et al.
Published: (2023-04-01)

Peroxiredoxins in Neurodegenerative Diseases
by: Monika Szeliga
Published: (2020-11-01)

Redox Regulation of PTEN by Peroxiredoxins
by: Thang Nguyen Huu, et al.
Published: (2021-02-01)

Cardiovascular risk in type 1 diabetes mellitus
by: Ines Ben Hadj Slama Slim
Published: (2013-01-01)

Peroxiredoxin, Senescence, and Cancer
by: Mengyao Wu, et al.
Published: (2022-05-01)

Peroxiredoxin post-translational modifications by redox messengers
by: Sylvie Riquier, et al.
Published: (2014-01-01)

Gender-Specific profiles of cardiovascular disease in type 2 diabetes mellitus: A cross-sectional study
by: Reem M Sallam, et al.
Published: (2018-01-01)

Essential Roles of Peroxiredoxin IV in Inflammation and Cancer
by: Pratik Thapa, et al.
Published: (2022-10-01)

The Role of Peroxiredoxins in the Regulation of Sepsis
by: Toshihiko Aki, et al.
Published: (2022-01-01)

CARDIOVASCULAR SAFETY IN THERAPY OF DIABETES MELLITUS TYPE 2
by: A. F. VERBOVOY, et al.
Published: (2016-12-01)

Peroxiredoxin 1 Protects Telomeres from Oxidative Damage and Preserves Telomeric DNA for Extension by Telomerase
by: Eric Aeby, et al.
Published: (2016-12-01)

Frequency of cardiovascular complications in patients with type 2 diabetes mellitus depending on antihyperglycemic therapy
by: Z.G. Krushinska, et al.
Published: (2018-09-01)

Progress on the pathogenesis of cardiovascular complications in patients with type 2 diabetes mellitus
by: ZHENG Tian-sheng, TONG Xue-wei, ZHANG Yi-tong, ZHU Min, ZHAN Xiao-rong
Published: (2022-05-01)

Blackcurrant Improves Diabetic Cardiovascular Dysfunction by Reducing Inflammatory Cytokines in Type 2 Diabetes Mellitus Mice
by: Hye-Yoom Kim, et al.
Published: (2021-11-01)

Metabolic and cardiovascular features of the course of type 2 diabetes mellitus in men with hypogonadism
by: T. Yu. Demidova, et al.
Published: (2022-06-01)

Cardiovascular Risk Profile and Prevalence of Microalbuminuria in Patients With Type 2 Diabetes Mellitus: The Campaign Disease Registry Results
by: Ebrahim M. A
Published: (2017-03-01)

Factors associated with cardiovascular disease in patients with type 2 diabetes mellitus
by: Tan, Mun Chieng
Published: (2013)

Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus
by: A S Ametov, et al.
Published: (2010-08-01)

Review of Postmortem Protein Oxidation in Skeletal Muscle and the Role of the Peroxiredoxin Family of Endogenous Antioxidants
by: Brian M Patterson, et al.
Published: (2023-02-01)

Protective Role of Peroxiredoxins against Reactive Oxygen Species in Neonatal Rat Testicular Gonocytes
by: Cristian O’Flaherty, et al.
Published: (2019-12-01)

The protective effect of peroxiredoxin II on oxidative stress induced apoptosis in pancreatic β-cells
by: Zhao Fang, et al.
Published: (2012-06-01)

Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus
by: Shuo Zhao, et al.
Published: (2021-12-01)

Modern approaches to management of cardiovascular risk factors at patients with diabetes mellitus type 2
by: A F Verbovoy, et al.
Published: (2018-08-01)

Characterisation of a niche-specific excretory–secretory peroxiredoxin from the parasitic nematode Teladorsagia circumcincta
by: Daniel R. G. Price, et al.
Published: (2019-07-01)

Improved glycemic control and cardiovascular risk in patients with diabetes mellitus Type II following cataract phacoemulsification surgery
by: Maria João Matias, et al.
Published: (2023-01-01)

Changes to insulin sensitivity in glucose clearance systems and redox following dietary supplementation with a novel cysteine-rich protein: A pilot randomized controlled trial in humans with type-2 diabetes
by: W.M. Peeters, et al.
Published: (2023-11-01)

The Role of Thioredoxin/Peroxiredoxin in the β-Cell Defense Against Oxidative Damage
by: Jennifer S. Stancill, et al.
Published: (2021-09-01)

GLYCOSYLATED HEMOGLOBIN AS A RISK ASSESSMENT OF THE CARDIOVASCULAR LESIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: О. Prystupiuk
Published: (2015-03-01)

Clinical factors associated with the recovery of cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus
by: Ji Eun Jun, et al.
Published: (2019-03-01)

Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
by: Hui-Ju Tsai, et al.
Published: (2021-08-01)

Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke
by: Dong‐Yi Chen, et al.
Published: (2020-01-01)

Radioprotective Role of Peroxiredoxin 6
by: Mars G. Sharapov, et al.
Published: (2019-01-01)

Diabetes mellitus is an independent risk factor for cardiovascular disease
by: A S Ametov, et al.
Published: (2012-08-01)

The effect of exogenous peroxiredoxin 6 on morphofunctional state of isolated rat kidney
by: A. E. Gordeeva, et al.
Published: (2021-09-01)

Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data
by: Cobble Michael E, et al.
Published: (2012-01-01)

Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study
by: Zirui Liu, et al.
Published: (2023-09-01)

Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study
by: Arnaud D. Kaze, et al.
Published: (2021-04-01)

Peroxiredoxin 3 levels regulate a mitochondrial redox setpoint in malignant mesothelioma cells
by: Brian Cunniff, et al.
Published: (2014-01-01)

Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT
by: Haiyan Zhu, et al.
Published: (2019-08-01)